Pulmonary alveolar proteinosis and paraneoplastic syndromes: manifestação paraneoplásica?
Autor(a) principal: | |
---|---|
Data de Publicação: | 2022 |
Outros Autores: | , , , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Clinical and Biomedical Research |
Texto Completo: | https://seer.ufrgs.br/index.php/hcpa/article/view/125272 |
Resumo: | Pulmonary alveolar proteinosis (PAP) is a rare condition of unknown etiology. It hasbeen described as the presence of periodic acid-Schiff-positive proteinaceous material(rich in lipids) in the alveoli. Its pathogenesis is believed to consist of an overproductionor surfactant removal defect at the lung. The association of PAP with respiratorydiseases, silicosis, exposure to aluminium or titanium, and hematological neoplasiashas been reported. Here we report two cases of pulmonary alveolar proteinosis andneoplasm diagnosed at the PulmonaryDepartment at Hospital de Clínicas de PortoAlegre. |
id |
UFRGS-20_84d3b06b533ededae92a0469bf310ffd |
---|---|
oai_identifier_str |
oai:seer.ufrgs.br:article/125272 |
network_acronym_str |
UFRGS-20 |
network_name_str |
Clinical and Biomedical Research |
repository_id_str |
|
spelling |
Pulmonary alveolar proteinosis and paraneoplastic syndromes: manifestação paraneoplásica?Proteinose alveolar: manifestação paraneoplásica?Proteinose alveolarparaneoplásicapulmonary alveolar proteinosisparaneoplasticPulmonary alveolar proteinosis (PAP) is a rare condition of unknown etiology. It hasbeen described as the presence of periodic acid-Schiff-positive proteinaceous material(rich in lipids) in the alveoli. Its pathogenesis is believed to consist of an overproductionor surfactant removal defect at the lung. The association of PAP with respiratorydiseases, silicosis, exposure to aluminium or titanium, and hematological neoplasiashas been reported. Here we report two cases of pulmonary alveolar proteinosis andneoplasm diagnosed at the PulmonaryDepartment at Hospital de Clínicas de PortoAlegre.A proteinose alveolar (PA) é uma doença rara, de etiologia desconhecida, caracterizadapelo acúmulo alveolar de material proteináceo PAS + (ácido-periódico de Schiff), ricoem fosfolipídios. Acredita-se que a patogênese consiste na superprodução ou defeitona remoção do surfactante ao nível do epitélio pulmonar (10). A PA pode estar associadaa infecções respiratórias (1,2), silicose (3), exposição ao alumínio (4), titânio (5) e aneoplasias hematológicas (6-8). Neste presente artigo, serão apresentados dois relatosde casos de proteinose alveolar e carcinomas diagnosticados no Serviço de Pneumologiado Hospital de Clínicas de Porto Alegre.HCPA/FAMED/UFRGS2022-06-15info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionPeer-reviewed ArticleAvaliado por paresapplication/pdfhttps://seer.ufrgs.br/index.php/hcpa/article/view/125272Clinical & Biomedical Research; Vol. 20 No. 1 (2000): Revista HCPAClinical and Biomedical Research; v. 20 n. 1 (2000): Revista HCPA2357-9730reponame:Clinical and Biomedical Researchinstname:Universidade Federal do Rio Grande do Sul (UFRGS)instacron:UFRGSporhttps://seer.ufrgs.br/index.php/hcpa/article/view/125272/85197http://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessPressi, Alexandre D. Furtado, André Chachamovich, Régis Henn, Lucélia M. Barreto, Sérgio 2022-09-16T16:33:00Zoai:seer.ufrgs.br:article/125272Revistahttps://www.seer.ufrgs.br/index.php/hcpaPUBhttps://seer.ufrgs.br/index.php/hcpa/oai||cbr@hcpa.edu.br2357-97302357-9730opendoar:2022-09-16T16:33Clinical and Biomedical Research - Universidade Federal do Rio Grande do Sul (UFRGS)false |
dc.title.none.fl_str_mv |
Pulmonary alveolar proteinosis and paraneoplastic syndromes: manifestação paraneoplásica? Proteinose alveolar: manifestação paraneoplásica? |
title |
Pulmonary alveolar proteinosis and paraneoplastic syndromes: manifestação paraneoplásica? |
spellingShingle |
Pulmonary alveolar proteinosis and paraneoplastic syndromes: manifestação paraneoplásica? Pressi, Alexandre Proteinose alveolar paraneoplásica pulmonary alveolar proteinosis paraneoplastic |
title_short |
Pulmonary alveolar proteinosis and paraneoplastic syndromes: manifestação paraneoplásica? |
title_full |
Pulmonary alveolar proteinosis and paraneoplastic syndromes: manifestação paraneoplásica? |
title_fullStr |
Pulmonary alveolar proteinosis and paraneoplastic syndromes: manifestação paraneoplásica? |
title_full_unstemmed |
Pulmonary alveolar proteinosis and paraneoplastic syndromes: manifestação paraneoplásica? |
title_sort |
Pulmonary alveolar proteinosis and paraneoplastic syndromes: manifestação paraneoplásica? |
author |
Pressi, Alexandre |
author_facet |
Pressi, Alexandre D. Furtado, André Chachamovich, Régis Henn, Lucélia M. Barreto, Sérgio |
author_role |
author |
author2 |
D. Furtado, André Chachamovich, Régis Henn, Lucélia M. Barreto, Sérgio |
author2_role |
author author author author |
dc.contributor.author.fl_str_mv |
Pressi, Alexandre D. Furtado, André Chachamovich, Régis Henn, Lucélia M. Barreto, Sérgio |
dc.subject.por.fl_str_mv |
Proteinose alveolar paraneoplásica pulmonary alveolar proteinosis paraneoplastic |
topic |
Proteinose alveolar paraneoplásica pulmonary alveolar proteinosis paraneoplastic |
description |
Pulmonary alveolar proteinosis (PAP) is a rare condition of unknown etiology. It hasbeen described as the presence of periodic acid-Schiff-positive proteinaceous material(rich in lipids) in the alveoli. Its pathogenesis is believed to consist of an overproductionor surfactant removal defect at the lung. The association of PAP with respiratorydiseases, silicosis, exposure to aluminium or titanium, and hematological neoplasiashas been reported. Here we report two cases of pulmonary alveolar proteinosis andneoplasm diagnosed at the PulmonaryDepartment at Hospital de Clínicas de PortoAlegre. |
publishDate |
2022 |
dc.date.none.fl_str_mv |
2022-06-15 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion Peer-reviewed Article Avaliado por pares |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://seer.ufrgs.br/index.php/hcpa/article/view/125272 |
url |
https://seer.ufrgs.br/index.php/hcpa/article/view/125272 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://seer.ufrgs.br/index.php/hcpa/article/view/125272/85197 |
dc.rights.driver.fl_str_mv |
http://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
http://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
HCPA/FAMED/UFRGS |
publisher.none.fl_str_mv |
HCPA/FAMED/UFRGS |
dc.source.none.fl_str_mv |
Clinical & Biomedical Research; Vol. 20 No. 1 (2000): Revista HCPA Clinical and Biomedical Research; v. 20 n. 1 (2000): Revista HCPA 2357-9730 reponame:Clinical and Biomedical Research instname:Universidade Federal do Rio Grande do Sul (UFRGS) instacron:UFRGS |
instname_str |
Universidade Federal do Rio Grande do Sul (UFRGS) |
instacron_str |
UFRGS |
institution |
UFRGS |
reponame_str |
Clinical and Biomedical Research |
collection |
Clinical and Biomedical Research |
repository.name.fl_str_mv |
Clinical and Biomedical Research - Universidade Federal do Rio Grande do Sul (UFRGS) |
repository.mail.fl_str_mv |
||cbr@hcpa.edu.br |
_version_ |
1799767056932929536 |